Triple Tumors Uncovered: Insights from ⁶⁸Ga PSMA PET-CT

Area of Science:

• Oncology
• Nuclear Medicine
• Radiology

Background:

• Prostate-specific membrane antigen (PSMA) is overexpressed in prostate cancer (PCa) and tumor neovasculature.
• ⁶⁸Ga PSMA PET-CT is a receptor-specific imaging modality increasingly used for PCa staging and restaging.
• PSMA expression is also observed in the neovasculature of various non-prostatic solid tumors.

Purpose of the Study:

• To present a case demonstrating the utility of ⁶⁸Ga PSMA PET-CT in identifying multiple tumors.
• To illustrate the potential of PSMA-targeted imaging beyond prostate cancer.

Main Methods:

• Utilized Gallium-68 prostate-specific membrane antigen positron emission tomography combined with computed tomography (⁶⁸Ga PSMA PET-CT).
• Performed follow-up imaging to confirm detected lesions.

Main Results:

• The ⁶⁸Ga PSMA PET-CT scan identified three distinct tumors.
• Subsequent imaging confirmed the presence of these three tumors.

Conclusions:

• ⁶⁸Ga PSMA PET-CT can effectively detect multiple tumors.
• This imaging technique shows promise for identifying tumors in various cancer types beyond prostate carcinoma.